Short Summary
Vectair Systems Inc.'s IPR challenge against Fresh Products, Inc.'s patent was denied by the PTAB. The Board found that the Petitioner failed to establish a reasonable likelihood of prevailing on grounds of anticipation (102) or obviousness (103).
Detailed Summary
The Patent Trial and Appeal Board denied institution for Vectair Systems Inc.'s Inter Partes Review against Fresh Products, Inc., concerning claims 1, 19, and 38 of patent 10,145,098 B2. The Petitioner asserted grounds of anticipation (Ground 1) based on Amazon Listings and obviousness (Grounds 2 and 3) using various prior art references such as Big D Catalog and FP Catalog Wave 2.0. The Board concluded that the Petitioner failed to demonstrate a reasonable likelihood of prevailing, specifically noting issues with the public accessibility of Amazon Listings and the lack of specific evidence supporting motivation to combine cited references for obviousness.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Vectair Systems Inc. vs Fresh Products, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Apple Inc.vsMyPort Technologies, Inc.
Apple has filed an IPR petition seeking to invalidate claims 6‑17 of MyPort’s ’017 patent, arguing they are obvious over prior‑art references Spatharis/Manjunath and Fuller/Jain. The petition references a prior IPR that was previously instituted and settled.
Shenzhen Fbtech Electronics Ltd. et al.vsLithiumHub Technologies, LLC et al.
Shenzhen FBTech and LiTime settled their IPR challenge to LithiumHub's patent 9,412,994, leading the PTAB to terminate the proceeding before trial and keep the settlement confidential.
GLOBALFOUNDRIES Inc. et al.vsOAK IP LLC
The PTAB found 11 of the 14 challenged claims of the ’395 patent unpatentable under 35 U.S.C. §102(b) due to anticipation by Grupp ’483, while claims 11, 12, and 14 survived. Written‑description and enablement challenges were rejected.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 patent covering intravascular embolism treatment devices after finding Imperative Care’s likelihood of success on at least one claim. The decision centers on claim constructions of the “filament” element and obviousness over multiple prior‑art references.
Cisco Systems, Inc.vs--
Cisco has filed an IPR petition seeking to invalidate Zugara’s AR video‑chat patent, asserting that its claims are obvious over the Rosenthal and Vesely publications. The petition lists 29 claims and relies on 35 U.S.C. §103.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.